These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 313293)

  • 1. Infantile thymectomy: alterations in circulating T-cell subpopulations and in vitro effects of thymopoietin pentapeptide.
    Gupta S; Kapoor N; Goldstein G; Good RA
    Clin Immunol Immunopathol; 1979 Apr; 12(4):404-9. PubMed ID: 313293
    [No Abstract]   [Full Text] [Related]  

  • 2. Subpopulations of human T lymphocytes. II. Effect of thymopoietin, corticosteroids, and irradiation.
    Gupta S; Good RA
    Cell Immunol; 1977 Nov; 34(1):10-8. PubMed ID: 303151
    [No Abstract]   [Full Text] [Related]  

  • 3. The in vitro effect of the thymic factor thymopoietin on a subpopulation of lymphocytes from severely malnourished children.
    Jackson TM; Zaman SN
    Clin Exp Immunol; 1980 Mar; 39(3):717-21. PubMed ID: 6769624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of the impaired lymphocyte stimulation in old people by thymopoietin pentapeptide.
    Verhaegen H; De Cock W; De Cree J; Goldstein G
    J Clin Lab Immunol; 1981 Sep; 6(2):103-5. PubMed ID: 7026790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte differentiations induced by thymopoietin, bursopoietin and ubiquitin.
    Goldstein G
    Symp Soc Dev Biol; 1978; (35):197-202. PubMed ID: 205966
    [No Abstract]   [Full Text] [Related]  

  • 6. A synthetic pentapeptide with biological activity characteristic of the thymic hormone thymopoietin.
    Goldstein G; Scheid MP; Boyse EA; Schlesinger DH; Van Wauwe J
    Science; 1979 Jun; 204(4399):1309-10. PubMed ID: 451537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoregulation by thymopoietin.
    Goldstein G; Lau CY
    J Supramol Struct; 1980; 14(3):397-403. PubMed ID: 6971374
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunoregulatory influence of thymic epithelium and thymopoietin on human B-lymphocyte differentiation.
    Pahwa S; Pahwa R; Goldstein G; Good RA
    Cell Immunol; 1980 Nov; 56(1):40-6. PubMed ID: 6968641
    [No Abstract]   [Full Text] [Related]  

  • 9. Thymopoietin enhances the allogeneic response and cyclic GMP levels of mouse peripheral, thymus-derived lymphocytes.
    Sunshine GH; Basch RS; Coffey RG; Cohen KW; Goldstein G; Hadden JW
    J Immunol; 1978 May; 120(5):1594-9. PubMed ID: 207773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory influence of thymopentin on splenic T cell sets of thymectomized and aged mice.
    Newcomb EW; Goldberg EH; de Sousa M; Goldstein G; Boyse EA; Scheid MP
    Transplantation; 1985 Nov; 40(5):520-7. PubMed ID: 3904090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymopoietin to thymopentin: experimental studies.
    Goldstein G; Audhya TK
    Surv Immunol Res; 1985; 4 Suppl 1():1-10. PubMed ID: 2994196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioassay determinations of thymopoietin and thymic hormone levels in human plasma.
    Twomey JJ; Goldstein G; Lewis VM; Bealmear PM; Good RA
    Proc Natl Acad Sci U S A; 1977 Jun; 74(6):2541-5. PubMed ID: 302007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymopoietin and bursopoietin: induction signals regulating early lymphocyte differentiation.
    Goldstein G; Scheid M; Boyse EA; Brand A; Gilmour DG
    Cold Spring Harb Symp Quant Biol; 1977; 41 Pt 1():5-8. PubMed ID: 196805
    [No Abstract]   [Full Text] [Related]  

  • 14. Thymic hormones and the immune system.
    Wara DW
    Adv Pediatr; 1981; 28():229-70. PubMed ID: 6280461
    [No Abstract]   [Full Text] [Related]  

  • 15. Syntheses and effects of [Glu34]-thymopoietin II fragment 32-45 and its analogs on the impaired T-cell transformation in a patient with common variable immunodeficiency.
    Abiko T; Shishido H; Sekino H
    Biotechnol Appl Biochem; 1986; 8(2-3):160-71. PubMed ID: 3488750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic possibilities of thymopoietin fragments (TP3 and TP4) based on experimental animal models.
    Dénes L; Szende B; Hajós G; Szporny L; Lapis K
    Drugs Exp Clin Res; 1987; 13(5):279-87. PubMed ID: 3500029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunological status of patients with recurrent herpes simplex infections. In vitro effect of thymopoietin and splenin-derived and partially modified peptides on peripheral blood lymphocytes in comparison to a thymus extract].
    Simon HU; Roth H; Forner K; Haroske D
    Allerg Immunol (Leipz); 1990; 36(2):111-8. PubMed ID: 1975471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of thymopoietin pentapeptide (TP-5) on in vitro and in vivo IgE production by atopic dermatitis cell subsets.
    Cooper KD; Kang K; Hanifin JM
    Diagn Immunol; 1983; 1(3):211-5. PubMed ID: 6388971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the TP5 analogue of thymopoietin on the rejection of male skin by aged and thymectomized female mice.
    Goldberg EH; Goldstein G; Boyse EA; Scheid MP
    Immunogenetics; 1981; 13(3):201-4. PubMed ID: 7024116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of thymopoietin pentapeptide on low reversible E-rosette forming cells of rheumatoid arthritis patients. -I) In vitro study.
    Auteri A; Laghi Pasini F; Pasqui AL; Bilenchi R; Di Perri T
    Boll Soc Ital Biol Sper; 1980 Feb; 56(4):308-11. PubMed ID: 7018514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.